RAB2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.755200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.497000E-01
Normal-vs-Stage2
2.750000E-01
Normal-vs-Stage3
7.724800E-01
Normal-vs-Stage4
1.689450E-01
Stage1-vs-Stage2
8.833000E-01
Stage1-vs-Stage3
3.726200E-01
Stage1-vs-Stage4
6.455000E-01
Stage2-vs-Stage3
3.799000E-01
Stage2-vs-Stage4
5.441800E-01
Stage3-vs-Stage4
2.477800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.732200E-01
Normal-vs-AfricanAmerican
2.897400E-01
Normal-vs-Asian
5.828000E-01
Caucasian-vs-AfricanAmerican
7.326600E-01
Caucasian-vs-Asian
5.249000E-01
AfricanAmerican-vs-Asian
5.767200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.076200E-01
Normal-vs-Female
2.374800E-01
Male-vs-Female
8.362000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.466200E-01
Normal-vs-Age(41-60Yrs)
9.645800E-02
Normal-vs-Age(61-80Yrs)
3.580800E-01
Normal-vs-Age(81-100Yrs)
4.115000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.136810E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.903800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.501600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.588000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.853800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.806000E-01
Normal-vs-Daily Drinker
5.831400E-01
Normal-vs-Weekly Drinker
3.823600E-01
Normal-vs-Occasional Drinker
1.997770E-01
Normal-vs-Social Drinker
1.866560E-01
Non Drinker-vs-Daily Drinker
8.006000E-01
Non Drinker-vs-Weekly Drinker
9.685200E-01
Non Drinker-vs-Occasional Drinker
1.664790E-01
Non Drinker-vs-Social Drinker
1.908580E-01
Daily Drinker-vs-Weekly Drinker
8.188200E-01
Daily Drinker-vs-Occasional Drinker
1.948980E-01
Daily Drinker-vs-Social Drinker
2.239000E-01
Weekly Drinker-vs-Occasional Drinker
2.735200E-01
Weekly Drinker-vs-Social Drinker
2.868800E-01
Occasional Drinker-vs-Social Drinker
9.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.866600E-01
Normal-vs-Grade 2
3.738400E-02
Normal-vs-Grade 3
6.424100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.399400E-01
Grade 1-vs-Grade 3
4.749800E-01
Grade 1-vs-Grade 4
2.866600E-01
Grade 2-vs-Grade 3
4.305000E-01
Grade 2-vs-Grade 4
3.738400E-02
Grade 3-vs-Grade 4
6.424100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.565200E-01
Normal-vs-NonDiabetic
3.046400E-01
Diabetic-vs-NonDiabetic
9.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.236000E-01
Normal-vs-NoPancreatitis
2.983600E-01
Pancreatitis-vs-NoPancreatitis
8.527600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.845200E-01
Normal-vs-N1
2.498600E-01
N0-vs-N1
5.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.332230E-01
Normal-vs-TP53-NonMutant
4.126600E-01
TP53-Mutant-vs-TP53-NonMutant
1.909640E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
